Poly Pharmaceuticals, Inc.
11 drugs in NADAC|11 Generic,0 Brand
Poly Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file (11 generic, 0 brand), at an average NADAC of $0.53 per unit, with a week-over-week move of -0.2% across products that moved. The firm's full portfolio, pricing trend are listed below.
Total Drugs
11
11G / 0B
Avg Price / Unit
$0.5264
$0.06 – $0.90
Avg 7d Change
-0.16%
Across 1 drugs with changes
7d Activity
of 11 total drugs
Portfolio Price Trend
Monthly average NADAC price across all drugs
Keep following this manufacturer
These next-step links connect the manufacturer page to the markets, classes, and trend views most likely to deepen research.
Lead market
ACETAMINOPHEN, DEXTROMETHORPHAN HBr, GUAIFENESIN, PSEUDOEPHEDRINE HCl market
See the molecule this manufacturer shows up in most often and compare it against competing suppliers.
Lead class
alpha-1 Adrenergic Agonist therapeutic class
Review the broader class where Poly Pharmaceuticals, Inc. has the strongest current portfolio footprint.
Trend hub
Portfolio trend view
Jump to the trend hub to compare this manufacturer against the rest of the market on weekly price movement.
Guide
NADAC pricing primer
Use the explainer for context on the benchmark this manufacturer is being compared against.
Frequently Asked Questions
How many drugs does Poly Pharmaceuticals, Inc. make?
Poly Pharmaceuticals, Inc. lists 11 NDCs in the CMS NADAC file — 11 generic and 0 brand products.
What is the average price of Poly Pharmaceuticals, Inc. drugs?
The average NADAC across Poly Pharmaceuticals, Inc.'s portfolio is $0.5264 per unit, ranging from $0.0614 to $0.9041.
What types of drugs does Poly Pharmaceuticals, Inc. make?
Poly Pharmaceuticals, Inc. makes drugs across 6 FDA pharmacologic classes. The most common by NDC count are alpha-1 Adrenergic Agonist (7), Sigma-1 Agonist (6), Uncompetitive N-methyl-D-aspartate Receptor Antagonist (6), Expectorant (5), alpha-Adrenergic Agonist (3).
Has Poly Pharmaceuticals, Inc. had any drug recalls?
No FDA enforcement recalls are matched to Poly Pharmaceuticals, Inc. in the openFDA feed.
How has Poly Pharmaceuticals, Inc.'s pricing changed recently?
Over the past 7 days, 0 Poly Pharmaceuticals, Inc. products rose and 1 fell, with a portfolio-wide average change of -0.2%.